课题基金 / 基金详情

Bench to beside translational studies to develop treatments for preeclampsia

Bench to beside translational studies to develop treatments for preeclampsia
结合转化研究开发先兆子痫治疗方法
批准号:
nhmrc : 1142636
负责人:
金额:
$18.07万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2021-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Preeclampsia is a common, devastating complication of pregnancy responsible for the loss of countless mothers and babies. There is no medical treatment. Excitingly we have identified 2 medications, safe in pregnancy: metformin and sulfasalazine that may treat this disease. We plan to introduce these medications into the clinic to see whether they may be an effective treatment for preeclampsia. If successful, these medications have the potential to improve the lives of women and babies globally.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金